Thursday, June 2, 2011

Ustekinumab 4-Year Data Show No Increased Cardiovascular Risk - Skin and Allergy News Digital Network

Ustekinumab 4-Year Data Show nary Increased Cardiovascular jeopardy Skin and hypersensitivity reaction News Digital system Major Finding: The observed combined charge of MI, stroke, and cardiovascular change in psoriasis patients on ustekinumab for at least iv years was 0.38 events per a hundred patient-years. Data Source: Ongoing open-label hold of major clinical trials of ... and more » Link To Article

No comments:

Post a Comment